Scimplify, a full-stack platform for specialty chemicals, has raised $40 million in a Series B funding round co-led by Accel and Bertelsmann India Investments.
The round also saw participation from UMI and existing investors including Omnivore and 3one4 Capital.
The funds raised will be used to scale its platform, accelerate its export expansion beyond the 16 countries it currently serves and expand both geographically and into new industry segments aggressively.
The company also plans to strengthen its presence in key industries such as life sciences, crop sciences, and industrial chemicals.
Scimplify also plans to aggressively expand its international footprint while continually adding new industry segments through enhanced R&D capabilities.
This latest round brings Scimplify’s total funding to $54 million, following $13.5 million raised across seed and Series A rounds.
“Global supply chains are shifting like never before. For decades, specialty chemical manufacturers have invested millions in facilities that can only produce a handful of compounds, often running at partial capacity while lacking R&D capabilities. This creates a paradox: excess capacity alongside supply shortages. We’ve flipped this model, connecting our scientific teams with hundreds of manufacturing plants to create a responsive ecosystem that can adapt as market needs shift,” said Sachin Santhosh, Co-Founder at Scimplify.
“Each specialty chemical requires significant scientific know-how and R&D investment. We’ve built a model that brings together the best scientific minds with hundreds of highly specialized manufacturing plants, creating a chemistry powerhouse that can tackle virtually any chemical challenge across critical industries,” he added.
Rachit Parekh, Principal at Accel said, “The global supply chain for specialty chemicals is at an inflection point. Traditional manufacturing supply chains, lack the flexibility required in todays geopolitical environment as well as the rapid changes in end customer requirements. Scimplify is building an R&D-led global manufacturing network which allows for flexibility coupled with innovation. At Accel, we have had a long standing thesis that R&D led speciality chemical companies which take advantage of the deep pool of manufacturing capabiltiies in India and globally can create global giants. We have been following the Scimplify journey from day 0 and their execution has been impressive. We look forward to this partnership and working with the team over the next decade.”
Rohit Sood, Partner at Bertelsmann India Investments said, “We are excited to significantly double down on our commitment to Scimplify, after our initial investment last year. Their execution on the ground has been among the best we’ve seen, driving not just impressive topline growth but also a rapid multi-country export scale-up and the establishment of a cutting-edge R&D facility in Hyderabad. Scimplify is uniquely positioned to harness India’s strengths in specialty chemicals and capitalize on the evolving dynamics of global procurement in this sector.”
Founded in 2023 by Salil Srivastava, Sachin Santhosh, and Dheeraj Dhingra, Scimplify is a full-stack platform for specialty chemicals, offering products across key industries like Agrochemicals, Pharmaceuticals, Flavors & Fragrances, Industrial Chemicals, and more.
With an in-house R&D team of scientists and a network of manufacturing plants, Scimplify delivers cost-efficient, scalable solutions globally to customers. Combining advanced technologies, sustainable practices, and digital capabilities, Scimplify transforms the chemical manufacturing value chain.
The company now serves leading innovators and manufacturers across life sciences, crop sciences, and industrial chemicals in major markets including the US, Europe and Japan.
